Your browser doesn't support javascript.
loading
A Pentanucleotide ATTTC Repeat Insertion in the Non-coding Region of DAB1, Mapping to SCA37, Causes Spinocerebellar Ataxia.
Seixas, Ana I; Loureiro, Joana R; Costa, Cristina; Ordóñez-Ugalde, Andrés; Marcelino, Hugo; Oliveira, Cláudia L; Loureiro, José L; Dhingra, Ashutosh; Brandão, Eva; Cruz, Vitor T; Timóteo, Angela; Quintáns, Beatriz; Rouleau, Guy A; Rizzu, Patrizia; Carracedo, Ángel; Bessa, José; Heutink, Peter; Sequeiros, Jorge; Sobrido, Maria J; Coutinho, Paula; Silveira, Isabel.
Affiliation
  • Seixas AI; UnIGENe, Instituto de Investigação e Inovação em Saúde, Universidade do Porto, 4200-135 Porto, Portugal; Institute for Molecular and Cell Biology, Universidade do Porto, 4200-135 Porto, Portugal.
  • Loureiro JR; Institute for Molecular and Cell Biology, Universidade do Porto, 4200-135 Porto, Portugal; Genetics of Cognitive Dysfunction Laboratory, Instituto de Investigação e Inovação em Saúde, Universidade do Porto, 4200-135 Porto, Portugal; Instituto de Ciências Biomédicas Abel Salazar, Universidade do Port
  • Costa C; Department of Neurology, Hospital Prof. Doutor Fernando Fonseca EPE, 2720-276 Amadora, Portugal.
  • Ordóñez-Ugalde A; Institute for Molecular and Cell Biology, Universidade do Porto, 4200-135 Porto, Portugal; Genetics of Cognitive Dysfunction Laboratory, Instituto de Investigação e Inovação em Saúde, Universidade do Porto, 4200-135 Porto, Portugal; Instituto de Investigación Sanitaria and Fundación Pública Galega d
  • Marcelino H; Institute for Molecular and Cell Biology, Universidade do Porto, 4200-135 Porto, Portugal; Vertebrate Development and Regeneration Laboratory, Instituto de Investigação e Inovação em Saúde, Universidade do Porto, 4200-135 Porto, Portugal.
  • Oliveira CL; Institute for Molecular and Cell Biology, Universidade do Porto, 4200-135 Porto, Portugal; Genetics of Cognitive Dysfunction Laboratory, Instituto de Investigação e Inovação em Saúde, Universidade do Porto, 4200-135 Porto, Portugal.
  • Loureiro JL; UnIGENe, Instituto de Investigação e Inovação em Saúde, Universidade do Porto, 4200-135 Porto, Portugal; Institute for Molecular and Cell Biology, Universidade do Porto, 4200-135 Porto, Portugal; Department of Neurology, Hospital São Sebastião, 4520-211 Feira, Portugal.
  • Dhingra A; German Center for Neurodegenerative Diseases, 72076 Tübingen, Germany.
  • Brandão E; Department of Neurology, Hospital São Sebastião, 4520-211 Feira, Portugal.
  • Cruz VT; Department of Neurology, Hospital São Sebastião, 4520-211 Feira, Portugal.
  • Timóteo A; Department of Neurology, Hospital Prof. Doutor Fernando Fonseca EPE, 2720-276 Amadora, Portugal.
  • Quintáns B; Instituto de Investigación Sanitaria and Fundación Pública Galega de Medicina Xenómica, Centro para Investigación Biomédica en Red de Enfermedades Raras, 15706 Santiago de Compostela, Spain.
  • Rouleau GA; Montreal Neurological Institute and Department of Neurology and Neurosurgery, McGill University, Montréal, QC H3A 2B4, Canada.
  • Rizzu P; German Center for Neurodegenerative Diseases, 72076 Tübingen, Germany.
  • Carracedo Á; Instituto de Investigación Sanitaria and Fundación Pública Galega de Medicina Xenómica, Centro para Investigación Biomédica en Red de Enfermedades Raras, 15706 Santiago de Compostela, Spain.
  • Bessa J; Institute for Molecular and Cell Biology, Universidade do Porto, 4200-135 Porto, Portugal; Vertebrate Development and Regeneration Laboratory, Instituto de Investigação e Inovação em Saúde, Universidade do Porto, 4200-135 Porto, Portugal.
  • Heutink P; German Center for Neurodegenerative Diseases, 72076 Tübingen, Germany.
  • Sequeiros J; UnIGENe, Instituto de Investigação e Inovação em Saúde, Universidade do Porto, 4200-135 Porto, Portugal; Institute for Molecular and Cell Biology, Universidade do Porto, 4200-135 Porto, Portugal; Instituto de Ciências Biomédicas Abel Salazar, Universidade do Porto, 4050-313 Porto, Portugal.
  • Sobrido MJ; Instituto de Investigación Sanitaria and Fundación Pública Galega de Medicina Xenómica, Centro para Investigación Biomédica en Red de Enfermedades Raras, 15706 Santiago de Compostela, Spain.
  • Coutinho P; UnIGENe, Instituto de Investigação e Inovação em Saúde, Universidade do Porto, 4200-135 Porto, Portugal; Institute for Molecular and Cell Biology, Universidade do Porto, 4200-135 Porto, Portugal.
  • Silveira I; Institute for Molecular and Cell Biology, Universidade do Porto, 4200-135 Porto, Portugal; Genetics of Cognitive Dysfunction Laboratory, Instituto de Investigação e Inovação em Saúde, Universidade do Porto, 4200-135 Porto, Portugal. Electronic address: isilveir@ibmc.up.pt.
Am J Hum Genet ; 101(1): 87-103, 2017 Jul 06.
Article in En | MEDLINE | ID: mdl-28686858
ABSTRACT
Advances in human genetics in recent years have largely been driven by next-generation sequencing (NGS); however, the discovery of disease-related gene mutations has been biased toward the exome because the large and very repetitive regions that characterize the non-coding genome remain difficult to reach by that technology. For autosomal-dominant spinocerebellar ataxias (SCAs), 28 genes have been identified, but only five SCAs originate from non-coding mutations. Over half of SCA-affected families, however, remain without a genetic diagnosis. We used genome-wide linkage analysis, NGS, and repeat analysis to identify an (ATTTC)n insertion in a polymorphic ATTTT repeat in DAB1 in chromosomal region 1p32.2 as the cause of autosomal-dominant SCA; this region has been previously linked to SCA37. The non-pathogenic and pathogenic alleles have the configurations [(ATTTT)7-400] and [(ATTTT)60-79(ATTTC)31-75(ATTTT)58-90], respectively. (ATTTC)n insertions are present on a distinct haplotype and show an inverse correlation between size and age of onset. In the DAB1-oriented strand, (ATTTC)n is located in 5' UTR introns of cerebellar-specific transcripts arising mostly during human fetal brain development from the usage of alternative promoters, but it is maintained in the adult cerebellum. Overexpression of the transfected (ATTTC)58 insertion, but not (ATTTT)n, leads to abnormal nuclear RNA accumulation. Zebrafish embryos injected with RNA of the (AUUUC)58 insertion, but not (AUUUU)n, showed lethal developmental malformations. Together, these results establish an unstable repeat insertion in DAB1 as a cause of cerebellar degeneration; on the basis of the genetic and phenotypic evidence, we propose this mutation as the molecular basis for SCA37.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Microsatellite Repeats / Genetic Predisposition to Disease / Physical Chromosome Mapping / Spinocerebellar Ataxias / DNA, Intergenic / Adaptor Proteins, Signal Transducing / Nerve Tissue Proteins Type of study: Etiology_studies Limits: Adolescent / Adult / Female / Humans / Male / Middle aged Language: En Journal: Am J Hum Genet Year: 2017 Document type: Article Affiliation country: Portugal

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Microsatellite Repeats / Genetic Predisposition to Disease / Physical Chromosome Mapping / Spinocerebellar Ataxias / DNA, Intergenic / Adaptor Proteins, Signal Transducing / Nerve Tissue Proteins Type of study: Etiology_studies Limits: Adolescent / Adult / Female / Humans / Male / Middle aged Language: En Journal: Am J Hum Genet Year: 2017 Document type: Article Affiliation country: Portugal